CXCL1 and hypopigmentation, organomegaly, and delayed myelination and development: Targeted inhibition of 14-3-3η by imICA prevented DEHP-modified secretion of IL-6 and CXCL1, and reversed the DEHP-caused liver lesions, functional disorders, and HOD in male mice